Ratan Tata invests in Invictus Oncology EP News Bureau Feb 9, 2016 The funds raised will be used to advance Invictus' lead molecule for completion of phase I clinical studies and to file an IND
Invictus Oncology to present data on IO-125 at Breast Cancer Symposium Sanjiv Das Sep 24, 2015 IO-125, a novel supramolecular platinum chemotherapy, is being developed in Triple-Negative Breast Cancer (TNBC) Invictus…
